| Jasmine Marybelle Zuchowski, | |
|
7940 Williams Pond Ln Ste 100, Charlotte, NC 28277-8410 | |
| (704) 752-7779 | |
| Not Available |
| Full Name | Jasmine Marybelle Zuchowski |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 7940 Williams Pond Ln Ste 100, Charlotte, North Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053902270 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 301676 (North Carolina) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | 5017105 (North Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jasmine Marybelle Zuchowski, 1901 Randolph Rd, Charlotte, NC 28207-1101 Ph: () - | Jasmine Marybelle Zuchowski, 7940 Williams Pond Ln Ste 100, Charlotte, NC 28277-8410 Ph: (704) 752-7779 |
News Archive
Edimer Pharmaceuticals, a biotechnology company focused on developing an innovative therapy for the rare genetic disorder, X-linked Hypohidrotic Ectodermal Dysplasia (XLHED), today announced the receipt of Fast Track designation from the U.S. Food and Drug Administration (FDA) for EDI200, the company's novel, proprietary, recombinant protein.
Babies born to women exposed to high ozone levels during pregnancy are at heightened risk for being significantly underweight, according to researchers at the Keck School of Medicine of the University of Southern California.
Amarin Corporation plc, a clinical-stage biopharmaceutical company with a focus on cardiovascular disease, today reported positive, statistically significant top-line results from the MARINE study, its first Phase 3 clinical trial of lead drug candidate AMR101.
BioInvent International AB and ThromboGenics NV announce that the positive results from a Phase II trial of TB-402 (Anti-Factor VIII antibody) were presented at the 21st International Congress on Thrombosis in Milan, Italy yesterday. TB-402 is a novel, long acting anticoagulant that is being developed as a single injection for the prevention of venous thromboembolism following orthopaedic surgery.
A new technology that increases the safety and precision of spinal fusion surgeries while reducing the time needed for the procedure now is available at Rush University Medical Center.
› Verified 1 days ago
Melissa E Jesse, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2236 Shenandoah Ave, Charlotte, NC 28205 Phone: 704-999-9857 | |
Mrs. Adrienne Dunlap Lane, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 200 Hawthorne Ln, Charlotte, NC 28204 Phone: 704-384-4109 | |
Melissa Renee Flood, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1225 Harding Pl, Ste 5100, Charlotte, NC 28204 Phone: 704-355-8850 | |
Anna Philbeck Burgess, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 4135 Southstream Blvd, Charlotte, NC 28217 Phone: 704-631-1200 | |
Stephanie Dawn Ferlic, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 6900 Farmingdale Dr, Charlotte, NC 28212 Phone: 704-910-5810 | |
Brooke Alyssa Davis, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2711 Randolph Rd Ste 400, Charlotte, NC 28207 Phone: 704-342-1900 Fax: 704-377-0353 | |
Angela Devincent Booth, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1001 Blythe Blvd, Medical Center Plaza Suite 200, Charlotte, NC 28203 Phone: 704-381-8840 |